Catherine Smith, MD, Assistant Professor, Division of Hematology/Oncology, Department of Medicine @UCSFMedicine tells us about the outcomes of the Phase 3 ADMIRAL trial and why it is important to the management of acute myeloid leukemia.
Advertisement